|
US2319808A
(en)
|
1939-08-31 |
1943-05-25 |
Squibb & Sons Inc |
Sterol derivatives and process for producing same
|
|
DE2417763A1
(de)
|
1974-04-11 |
1975-10-30 |
Bayer Ag |
Carbonsaeureamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
|
|
US4992417A
(en)
|
1987-07-17 |
1991-02-12 |
Mount Sinai School Of Medicine |
Superactive human insulin analogues
|
|
US4992418A
(en)
|
1987-07-17 |
1991-02-12 |
Mount Sinai School Of Medicine |
Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin
|
|
JPH01203351A
(ja)
|
1988-02-05 |
1989-08-16 |
Mitsui Petrochem Ind Ltd |
１，４−ジヒドロキシナフタレン誘導体および医薬
|
|
JPH023351A
(ja)
|
1988-06-16 |
1990-01-08 |
Oki Electric Ind Co Ltd |
印刷装置
|
|
US4861891A
(en)
|
1988-08-31 |
1989-08-29 |
Pfizer Inc. |
Antidepressant N-substituted nicotinamide compounds
|
|
US5514646A
(en)
|
1989-02-09 |
1996-05-07 |
Chance; Ronald E. |
Insulin analogs modified at position 29 of the B chain
|
|
JPH03184973A
(ja)
|
1989-12-14 |
1991-08-12 |
Rooman Kogyo:Kk |
放射線障害防護剤
|
|
US5260323A
(en)
*
|
1990-06-28 |
1993-11-09 |
Hoechst Aktiengesellschaft |
2,4- and 2,5-substituted pyridine-N-oxides, processes for their preparation and their use
|
|
TW197439B
(https=)
|
1991-04-04 |
1993-01-01 |
Ueno Pharmaceutics Applic Res Co Ltd |
|
|
US5283253A
(en)
|
1991-09-23 |
1994-02-01 |
Florida State University |
Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them
|
|
DE4201047A1
(de)
|
1992-01-17 |
1993-07-22 |
Bayer Ag |
Substituierte isoxazolcarbonsaeureamide
|
|
US5272137A
(en)
|
1992-02-14 |
1993-12-21 |
Mcneil-Pfc, Inc. |
Aqueous pharmaceutical suspension for pharmaceutical actives
|
|
US5200534A
(en)
|
1992-03-13 |
1993-04-06 |
University Of Florida |
Process for the preparation of taxol and 10-deacetyltaxol
|
|
US5294637A
(en)
|
1992-07-01 |
1994-03-15 |
Bristol-Myers Squibb Company |
Fluoro taxols
|
|
JP2994182B2
(ja)
|
1992-07-23 |
1999-12-27 |
石原産業株式会社 |
アミド系化合物又はその塩、それらの製造方法及びそれらを含有する有害動物防除剤
|
|
US5202448A
(en)
|
1992-08-14 |
1993-04-13 |
Napro Biotherapeutics, Inc. |
Processes of converting taxanes into baccatin III
|
|
US5415869A
(en)
|
1993-11-12 |
1995-05-16 |
The Research Foundation Of State University Of New York |
Taxol formulation
|
|
US5504188A
(en)
|
1994-06-16 |
1996-04-02 |
Eli Lilly And Company |
Preparation of stable zinc insulin analog crystals
|
|
US5461031A
(en)
|
1994-06-16 |
1995-10-24 |
Eli Lilly And Company |
Monomeric insulin analog formulations
|
|
US5474978A
(en)
|
1994-06-16 |
1995-12-12 |
Eli Lilly And Company |
Insulin analog formulations
|
|
US5547929A
(en)
|
1994-09-12 |
1996-08-20 |
Eli Lilly And Company |
Insulin analog formulations
|
|
US5693609A
(en)
|
1994-11-17 |
1997-12-02 |
Eli Lilly And Company |
Acylated insulin analogs
|
|
JP3833281B2
(ja)
*
|
1995-02-03 |
2006-10-11 |
日本曹達株式会社 |
２，６−ジクロロイソニコチン酸ベンジルアミド誘導体及び植物病害防除剤
|
|
YU18596A
(sh)
|
1995-03-31 |
1998-07-10 |
Eli Lilly And Company |
Analogne formulacije monomernog insulina
|
|
PT1019385E
(pt)
|
1995-09-15 |
2004-06-30 |
Upjohn Co |
N-oxidos de aminoaril-oxazolidinona
|
|
US6072050A
(en)
|
1996-06-11 |
2000-06-06 |
Pioneer Hi-Bred International, Inc. |
Synthetic promoters
|
|
FR2751645B1
(fr)
|
1996-07-29 |
1998-12-24 |
Sanofi Sa |
Amines pour la fabrication de medicaments destines a empecher la proliferation de cellules tumorales
|
|
ZA984697B
(en)
|
1997-06-13 |
1999-12-01 |
Lilly Co Eli |
Stable insulin formulations.
|
|
BR9813331A
(pt)
*
|
1997-10-31 |
2000-08-22 |
Aventis Pharma Ltd |
Composto, uso do mesmo, composição farmacêutica, processo para o tratamento de um paciente humano ou animal não humano que sofra ou esteja sujeito a condições que possam ser melhoradas pela administração de um inibidor da adesão celular mediada pela a4b1, e, resina
|
|
AU1832099A
(en)
|
1997-12-22 |
1999-07-12 |
Eli Lilly And Company |
Catalyst and method for amide formation
|
|
US6384080B1
(en)
|
1998-04-20 |
2002-05-07 |
Fujisawa Pharmaceutical Co., Ltd. |
Anthranilic acid derivatives as inhibitors of the cGMP-phosphodiesterase
|
|
AR019190A1
(es)
|
1998-07-08 |
2001-12-26 |
Sod Conseils Rech Applic |
Derivados de 2-aminopiridinas, productos intermedios para su preparacion, medicamentos y composiciones farmaceuticas que los contienen y su uso para preparar medicamentos
|
|
US6780883B2
(en)
|
1998-11-05 |
2004-08-24 |
Warner-Lambert Company |
Amide inhibitors of microsomal triglyceride transfer protein
|
|
ATE276241T1
(de)
|
1998-11-25 |
2004-10-15 |
Yissum Res Dev Co |
Antioxidationsmittel
|
|
GB9919558D0
(en)
*
|
1999-08-18 |
1999-10-20 |
Hoechst Schering Agrevo Gmbh |
Fungicidal compounds
|
|
WO2001032928A2
(en)
|
1999-11-05 |
2001-05-10 |
Phase-1 Molecular Toxicology |
Methods of determining individual hypersensitivity to an agent
|
|
EP1402026A2
(en)
|
2000-04-18 |
2004-03-31 |
Millennium Pharmaceuticals, Inc. |
39228, a human alcohol dehydrogenase and uses therefor
|
|
WO2002020500A2
(en)
|
2000-09-01 |
2002-03-14 |
Icos Corporation |
Materials and methods to potentiate cancer treatment
|
|
CA2419224A1
(en)
*
|
2000-09-15 |
2002-03-21 |
Anormed Inc. |
Chemokine receptor binding heterocyclic compounds
|
|
US6835731B2
(en)
*
|
2000-09-15 |
2004-12-28 |
Anormed, Inc. |
Chemokine receptor binding heterocyclic compounds
|
|
US7141590B2
(en)
*
|
2000-12-29 |
2006-11-28 |
Ucb Sa |
Pharmaceutical uses and synthesis of nicotinanilide-N-oxides
|
|
DOP2002000332A
(es)
*
|
2001-02-14 |
2002-08-30 |
Warner Lambert Co |
Inhibidores de piridina de metaloproteinasas de la matriz
|
|
US6678516B2
(en)
|
2001-05-21 |
2004-01-13 |
Nokia Corporation |
Method, system, and apparatus for providing services in a privacy enabled mobile and Ubicom environment
|
|
JP4448902B2
(ja)
|
2001-06-08 |
2010-04-14 |
株式会社医薬分子設計研究所 |
スルホンアミド誘導体
|
|
JPWO2003030937A1
(ja)
|
2001-10-05 |
2005-01-20 |
小野薬品工業株式会社 |
ミトコンドリアルベンゾジアゼピン受容体アンタゴニストからなるストレス疾患の治療剤
|
|
DE10149674A1
(de)
*
|
2001-10-09 |
2003-04-24 |
Apogepha Arzneimittel Gmbh |
Orale Darreichungsformen für Propiverin oder seinen pharmazeutisch annehmbaren Salzen mit verlängerter Wirkstoffreisetzung
|
|
US20030100034A1
(en)
*
|
2001-10-16 |
2003-05-29 |
Millennium Pharmaceuticals, Inc. |
9136, a human aldehyde dehydrogenase family member and uses therefor
|
|
PY0300568A
(es)
|
2002-01-31 |
2004-10-01 |
Pfizer Prod Inc |
Metabolitos del acido(3-{[4-terc-butilbencil)-(piridin-3-sulfonil)amino]metil}fenoxi)acetico
|
|
PT1477186E
(pt)
|
2002-02-19 |
2010-02-11 |
Shionogi & Co |
Antipruriginosos
|
|
JP4595059B2
(ja)
|
2002-04-18 |
2010-12-08 |
株式会社医薬分子設計研究所 |
アミド誘導体
|
|
GB0215650D0
(en)
|
2002-07-05 |
2002-08-14 |
Cyclacel Ltd |
Bisarylsufonamide compounds
|
|
CN1732161A
(zh)
|
2002-09-06 |
2006-02-08 |
艾伦药物公司 |
1,3－二氨基－2－羟基丙烷前体药物衍生物
|
|
EP1402888A1
(en)
|
2002-09-18 |
2004-03-31 |
Jerini AG |
The use of substituted carbocyclic compounds as rotamases inhibitors
|
|
EP1402887A1
(en)
|
2002-09-18 |
2004-03-31 |
Jerini AG |
New compounds for the inhibition of undesired cell proliferation and use thereof
|
|
US7135575B2
(en)
|
2003-03-03 |
2006-11-14 |
Array Biopharma, Inc. |
P38 inhibitors and methods of use thereof
|
|
US7022850B2
(en)
|
2003-05-22 |
2006-04-04 |
Bristol-Myers Squibb Co. |
Bicyclicpyrimidones and their use to treat diseases
|
|
JP4359754B2
(ja)
*
|
2003-07-03 |
2009-11-04 |
三菱瓦斯化学株式会社 |
基板の洗浄剤
|
|
WO2005007889A1
(en)
|
2003-07-21 |
2005-01-27 |
Oncotherapy Science, Inc. |
Method for diagnosing colorectal cancers
|
|
WO2005011561A2
(en)
|
2003-08-04 |
2005-02-10 |
Labcoat, Ltd. |
Stent coating apparatus and method
|
|
GB0318814D0
(en)
*
|
2003-08-11 |
2003-09-10 |
Smithkline Beecham Corp |
Novel compounds
|
|
JPWO2005016351A1
(ja)
|
2003-08-18 |
2006-10-12 |
塩野義製薬株式会社 |
カンナビノイド受容体アゴニストの新規用途
|
|
FR2861074B1
(fr)
|
2003-10-17 |
2006-04-07 |
Sanofi Synthelabo |
Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
|
|
FR2861071B1
(fr)
|
2003-10-17 |
2006-01-06 |
Sanofi Synthelabo |
Derives de n-[phenyl(alkylpiperidin-2-yl) methyl]benzamide, leur prepartation et leur application en therapeutique
|
|
WO2005057213A1
(en)
|
2003-12-09 |
2005-06-23 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions for modulating mitochondrial aldehyde dehydrogenase-2
|
|
GT200500013A
(es)
*
|
2004-01-23 |
2005-08-10 |
|
Amidas herbicidas
|
|
WO2005084392A2
(en)
|
2004-03-03 |
2005-09-15 |
Convivia |
4-methylpyrazole formulations for inhibiting ethanol intolerance
|
|
WO2005110422A2
(en)
|
2004-05-19 |
2005-11-24 |
Boehringer Ingelheim International Gmbh |
Treatment of diseases associated with altered level of amyloid beta peptides
|
|
CN1749415A
(zh)
|
2004-09-15 |
2006-03-22 |
上海人类基因组研究中心 |
硝酸甘油治疗急性心绞痛疗效检测方法和试剂盒
|
|
US7456194B2
(en)
*
|
2004-11-12 |
2008-11-25 |
Bristol-Myers Squibb Company |
Imidazo-fused oxazolo [4,5-b]pyridine and imidazo-fused thiazolo[4,5-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same
|
|
US7888374B2
(en)
*
|
2005-01-28 |
2011-02-15 |
Abbott Laboratories |
Inhibitors of c-jun N-terminal kinases
|
|
DOP2006000051A
(es)
|
2005-02-24 |
2006-08-31 |
Lilly Co Eli |
Inhibidores de vegf-r2 y métodos
|
|
NZ566136A
(en)
|
2005-09-23 |
2010-04-30 |
Pfizer Prod Inc |
Pyridinaminosulfonyl substituted benzamides as inhibitors of cytochrome p450 3a4 (cyp3a4)
|
|
WO2007075783A2
(en)
|
2005-12-22 |
2007-07-05 |
Wyeth |
Substituted isoquinoline-1,3(2h,4h)-diones, 1-thioxo-1,4-dihydro-2h-isoquinoline-3-ones and 1,4-dihydro-3(2h)-isoquinolones and use thereof as kinase inhibitor
|
|
EP2001851A2
(en)
*
|
2006-03-28 |
2008-12-17 |
Novartis AG |
Amide derivatives and their application for the treament of g protein related diseases
|
|
EP2742936A1
(en)
|
2006-05-16 |
2014-06-18 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic compound and use thereof
|
|
WO2007136707A2
(en)
|
2006-05-17 |
2007-11-29 |
University Of Utah Research Foundation |
Methods and compositions related to eosinophil regulation
|
|
US20080003585A1
(en)
|
2006-06-29 |
2008-01-03 |
Bio-Rad Laboratories, Inc., A Corporation Of The State Of Delaware |
Purification and amplification of nucleic acids in a microfluidic device
|
|
EP2046769A2
(en)
|
2006-07-27 |
2009-04-15 |
Cv Therapeutics, Inc. |
Aldh-2 inhibitors in the treatment of addiction
|
|
PE20080906A1
(es)
|
2006-08-17 |
2008-07-05 |
Kemia Inc |
Derivados heteroarilo como inhibidores de citocina
|
|
US8927715B2
(en)
|
2006-08-25 |
2015-01-06 |
Vitae Pharmaceuticals, Inc. |
Inhibitors of 11β-hydroxysteroid dehydrogenase type 1
|
|
DE602006021591D1
(de)
*
|
2006-12-11 |
2011-06-09 |
Genetics Co Inc |
Aromatische 1,4-DI-Carboxylamide und deren Verwendung
|
|
US20100298314A1
(en)
|
2006-12-20 |
2010-11-25 |
Schering Corporation |
Novel jnk inhibitors
|
|
CN101611007A
(zh)
*
|
2006-12-20 |
2009-12-23 |
先灵公司 |
新颖的jnk抑制剂
|
|
WO2008103354A2
(en)
|
2007-02-20 |
2008-08-28 |
Cropsolution, Inc. |
Modulators of acetyl-coenzyme a carboxylase and methods of use thereof
|
|
KR20090117950A
(ko)
|
2007-03-08 |
2009-11-16 |
더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 |
미토콘드리아 알데히드 탈수소효소-2 조절자 및 그것의 사용 방법
|
|
CA2709784A1
(en)
|
2007-12-21 |
2009-07-09 |
University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
WO2009137045A2
(en)
|
2008-05-07 |
2009-11-12 |
The Board Of Trustees Of The Leland Stanford Junior University |
Crystal structure of aldehyde dehydrogenase and methods of use thereof
|
|
AU2009253812A1
(en)
|
2008-06-04 |
2009-12-10 |
Ambrilia Biopharma Inc. |
HIV integrase inhibitors from pyridoxine
|
|
EP2307379A2
(en)
|
2008-06-27 |
2011-04-13 |
Novartis AG |
Organic compounds
|
|
EP2337563B1
(en)
|
2008-09-08 |
2014-04-09 |
The Board of Trustees of The Leland Stanford Junior University |
Modulators of aldehyde dehydrogenase activity and methods of use thereof
|
|
KR20110082180A
(ko)
|
2008-10-28 |
2011-07-18 |
더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 |
알데히드 탈수소효소의 조절자 및 그것의 사용방법
|
|
EP2435407B1
(en)
|
2009-05-29 |
2019-12-25 |
RaQualia Pharma Inc. |
Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
|
|
PE20140199A1
(es)
|
2010-10-20 |
2014-02-16 |
Gruenenthal Chemie |
6-amino-nicotinamidas sustituidas como moduladores de kcnq2/3
|
|
EP2651412A4
(en)
|
2010-12-14 |
2014-08-13 |
Beth Israel Hospital |
ANDROGEN RECEPTOR AND HER APPLICATION PROCEDURES
|
|
WO2012106534A2
(en)
|
2011-02-02 |
2012-08-09 |
The Regents Of The University Of California |
Hiv integrase inhibitors
|
|
WO2012149106A1
(en)
|
2011-04-29 |
2012-11-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for increasing proliferation of adult salivary stem cells
|
|
KR20140075693A
(ko)
|
2011-08-29 |
2014-06-19 |
인피니티 파마슈티칼스, 인코포레이티드 |
헤테로사이클릭 화합물 및 그의 용도
|